Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florent Grange

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
JAMA Dermatology|July 24, 2014
High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-typeAnne Pham-Ledard, Marie Beylot-Barry, Coralie Barbe, et al.
Cancer|January 11, 2011
Characteristics of the coexistence of melanoma and renal cell carcinomaEve Maubec, Valérie Chaudru, Hamida Mohamdi, et al.
JAMA Dermatology|November 15, 2013
Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective studyFanny Fichel, Coralie Barbe, Pascal Joly, et al.
The American Journal of Surgical Pathology|November 29, 2007
Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?Tony Petrella, Eve Maubec, Pascale Cornillet-Lefebvre, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2013
Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphomaAnne Pham-Ledard, Martina Prochazkova-Carlotti, Laetitia Andrique, et al.
BMC Cancer|December 24, 2015
Prevalence of hepatitis B and C and sensibility of a selective screening questionnaire in patients receiving chemotherapy for solid tumorsMathilde Brasseur, Alexandra Heurgué-Berlot, Coralie Barbe, et al.
The Oncologist|December 16, 2015
Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid PapulosisNadège Cordel, Benoît Tressières, Michel D'Incan, et al.
International Journal of Clinical Practice|May 17, 2017
Treatment patterns and outcomes of Stage IIIB/IIIC melanoma in France, Germany and the UK: A retrospective and prospective observational study (MELABIS)Mark Harries, Peter Mohr, Florent Grange, et al.
Melanoma Research|August 12, 2017
Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study)Florent Grange, Peter Mohr, Mark Harries, et al.
ESMO Open|August 11, 2018
Association of homogeneous inflamed gene signature with a better outcome in patients with metastatic melanoma treated with MAGE-A3 immunotherapeuticJean-François Baurain, Caroline Robert, Laurent Mortier, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
JAMA Dermatology|July 24, 2014
High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-typeAnne Pham-Ledard, Marie Beylot-Barry, Coralie Barbe, et al.
Cancer|January 11, 2011
Characteristics of the coexistence of melanoma and renal cell carcinomaEve Maubec, Valérie Chaudru, Hamida Mohamdi, et al.
JAMA Dermatology|November 15, 2013
Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective studyFanny Fichel, Coralie Barbe, Pascal Joly, et al.
The American Journal of Surgical Pathology|November 29, 2007
Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?Tony Petrella, Eve Maubec, Pascale Cornillet-Lefebvre, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2013
Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphomaAnne Pham-Ledard, Martina Prochazkova-Carlotti, Laetitia Andrique, et al.
BMC Cancer|December 24, 2015
Prevalence of hepatitis B and C and sensibility of a selective screening questionnaire in patients receiving chemotherapy for solid tumorsMathilde Brasseur, Alexandra Heurgué-Berlot, Coralie Barbe, et al.
The Oncologist|December 16, 2015
Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid PapulosisNadège Cordel, Benoît Tressières, Michel D'Incan, et al.
International Journal of Clinical Practice|May 17, 2017
Treatment patterns and outcomes of Stage IIIB/IIIC melanoma in France, Germany and the UK: A retrospective and prospective observational study (MELABIS)Mark Harries, Peter Mohr, Florent Grange, et al.
Melanoma Research|August 12, 2017
Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study)Florent Grange, Peter Mohr, Mark Harries, et al.
ESMO Open|August 11, 2018
Association of homogeneous inflamed gene signature with a better outcome in patients with metastatic melanoma treated with MAGE-A3 immunotherapeuticJean-François Baurain, Caroline Robert, Laurent Mortier, et al.
Pageof 8